Tag: CBT > CBD FDA: Page 4

Compliance
The FDA Wants to Test Thousands of CBD Products on the Market
The move comes as the administration continues to tilt toward some form of federal regulation for the CBD industry.
August 18, 2020
Arizona
Nevada Compliance Board Holds Inaugural Meeting, FDA Issues Much-Anticipated Report: Week in Review
The newly established Nevada Cannabis Compliance Board met for the first time this week and signed off on a disciplinary settlement that will revoke six of CWNevada’s 14 licenses.
July 25, 2020
Marijuana Leaves On Wood Adobe Stock Credit Yeko Photo Studio Resized
CBD Industry
FDA Submits ‘Cannabidiol Enforcement Policy’ Draft to White House
While the contents of the document are still unknown, the FDA described it as “draft guidance for the industry.”
July 24, 2020
Adobe Stockkostrezresized
Legislation and Regulation
Illinois Delays Awarding New Cannabis Dispensary Licenses, Canopy Growth Lays off 200 More Workers: Week in Review
This week, Illinois regulators planned to issue 75 adult-use dispensary licenses, but instead announced that they will now wait until the governor’s disaster proclamation expires.
May 2, 2020
Marijuana Adobe Stock Credit Capjah Resized
CBD Industry
FDA Warns Two Companies to Stop Marketing CBD as Opioid Addiction Treatment
The letters were sent to BIOTA Biosciences LLC and Homero Corp, the latter of which conducts business as Natures CBD Oil Distribution.
April 30, 2020
Fda Resized
Home
End Notes
Quotes you should note.
April 3, 2020
Ssp 6651 Fmt
Finance
Charlotte’s Web Reports $18.8M Q4 Loss, Executives Discuss Challenges and the Future
In a recent earnings call, Charlotte’s Web executives discussed a drop in Q4 sales due to regulatory uncertainty, its recent Abacus acquisition and how the coronavirus will impact business.
March 27, 2020
Finance
CV Sciences Reveals FY 2019 Earnings, Discusses Future Amid Coronavirus Outbreak
In a recent earnings call, company executives discussed challenges they endured in 2019 and what they're facing in 2020.
March 19, 2020
Adult-Use Legalization Bill
Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research
The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.
January 17, 2020
Capitol Gary
Top Stories
At the Starting Line
CTPharma worked for five years to launch an FDA-approved clinical trial in partnership with Yale School of Medicine. Now that the company has the go-ahead, the real work begins.
December 18, 2019
Ctpharma
Finance
The Cannabis Industry’s 9 Biggest Moments of 2019
This year saw many milestones, from historic votes in Congress to states launching cannabis sales for the first time.
December 9, 2019
Marijuana Plant Indoors Adobe Stock Credit Kyle Resized
Legislation and Regulation
Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market
Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.
December 6, 2019
Previous Page
Page 4 of 6
Next Page